SMALL INTERFERING RNA TARGETING FOCAL ADHESION KINASE PREVENTS CARDIAC DYSFUNCTION IN ENDOTOXEMIA

Imagem de Miniatura
Arquivos
art_GUIDO_SMALL_INTERFERING_RNA_TARGETING_FOCAL_ADHESION_KINASE_PREVENTS_2012.PDF (2 MB)
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
CLEMENTE, Carolina F.
FRANCHINI, Kleber G.
Citação
SHOCK, v.37, n.1, p.77-84, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Sepsis and septic shock are associated with cardiac depression. Cardiovascular instability is a major cause of death in patients with sepsis. Focal adhesion kinase (FAK) is a potential mediator of cardiomyocyte responses to oxidative and mechanical stress. Myocardial collagen deposition can affect cardiac compliance and contractility. The aim of the present study was to determine whether the silencing of FAK is protective against endotoxemia-induced alterations of cardiac structure and function. In male Wistar rats, endotoxemia was induced by intraperitoneal injection of lipopolysaccharide (10 mg/kg). Cardiac morphometry and function were studied in vivo by left ventricular catheterization and histology. Intravenous injection of small interfering RNA targeting FAK was used to silence myocardial expression of the kinase. The hearts of lipopolysaccharide-injected rats showed collagen deposition, increased matrix metalloproteinase 2 activity, and myocyte hypertrophy, as well as reduced 24-h +dP/dt and -dP/dt, together with hypotension, increased left ventricular end-diastolic pressure, and elevated levels of FAK (phosphorylated and unphosphorylated). Focal adhesion kinase silencing reduced the expression and activation of the kinase in cardiac tissue, as well as protecting against the increased collagen deposition, greater matrix metalloproteinase 2 activity, and reduced cardiac contractility that occur during endotoxemia. In conclusion, FAK is activated in endotoxemia, playing a role in cardiac remodeling and in the impairment of cardiac function. This kinase represents a potential therapeutic target for the protection of cardiac function in patients with sepsis.
Palavras-chave
Focal adhesion protein-tyrosine kinases, cytokines, inflammation, sepsis, shock septic
URI
https://observatorio.fm.usp.br/handle/OPI/1014
Referências
  1. Aoyama T, 2010, GASTROENTEROL RES PR
  2. Barbeiro DF, 2011, IMMUNOBIOLOGY, V216, P302, DOI 10.1016/j.imbio.2010.08.002
  3. Bergman MR, 2007, AM J PHYSIOL-HEART C, V292, pH1847, DOI 10.1152/ajpheart.00434.2006
  4. Cazita PM, 2008, SHOCK, V30, P590, DOI 10.1097/SHK.0b013e31816e30fd
  5. Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a
  6. Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978
  7. Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007
  8. Eble DM, 2000, AM J PHYSIOL-HEART C, V278, pH1695
  9. FALLACH R, 2011, J MOL CELL CARDIOL, V48, P1236
  10. Guido MC, 2007, CLIN EXP PHARMACOL P, V34, P1165, DOI 10.1111/j.1440-1681.2007.04689.x
  11. Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.040621101
  12. He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690
  13. Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001
  14. Jones AE, 2009, CRIT CARE CLIN, V25, P769, DOI 10.1016/j.ccc.2009.06.003
  15. KATZ AM, 1994, ANN INTERN MED, V121, P363
  16. Kluwe J, 2009, J MOL MED-JMM, V87, P125, DOI 10.1007/s00109-008-0426-z
  17. Gaddnas F, 2009, CRIT CARE, V13, DOI 10.1186/cc7780
  18. LORIGADOS CB, 2011, ENDOCR METAB IMMUNE, V10, P274
  19. MELO ES, 2011, IMMUNOBIOLOGY, V215, P435
  20. MELO ES, 2011, MOL IMMUNOL, V47, P2587
  21. Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011
  22. NATANSON C, 1989, J EXP MED, V169, P823, DOI 10.1084/jem.169.3.823
  23. Negri EM, 2000, HISTOPATHOLOGY, V37, P393, DOI 10.1046/j.1365-2559.2000.00992.x
  24. Nogueira AC, 2008, SHOCK, V29, P342
  25. Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7
  26. PARKER MM, 1990, CHEST, V97, P126, DOI 10.1378/chest.97.1.126
  27. Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004
  28. SALDIVA PHN, 1989, CHEST, V95, P953, DOI 10.1378/chest.95.5.953
  29. Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
  30. Sorensen DR, 2003, J MOL BIOL, V327, P761, DOI 10.1016/S0022-2836(03)00181-5
  31. Soriano FG, 2006, CRIT CARE MED, V34, P1073, DOI 10.1097/01.CCM.0000206470.47721.8D
  32. Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008
  33. Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199
  34. Vincent JL, 2002, CLIN INFECT DIS, V34, P1084, DOI 10.1086/339549
  35. Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e
  36. Zeisel MB, 2005, J IMMUNOL, V174, P7393

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/19
Carregar mais